RecallWatchUSA

Home / Recalls / Drugs

PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only, Pharmaceutic

Recalled August 19, 2020 · FDA recall D-1494-2020 · PAI Holdings, LLC.

Hazard
Subpotent drug: Out of specification for assay at the 15-month test interval. · FDA Class II
Units
7416 bottles
Sold at
Nationwide USA

Description

Subpotent drug: Out of specification for assay at the 15-month test interval.

Product
Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0810-16
Manufacturer(s)
PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov

PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only, Pharmaceutic | RecallWatchUSA